Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-FR
Language English French
Date Updated 2019-09-17 2019-09-10
Drug Identification Number 02172771 02172771
Brand name OMNISCAN OMNISCAN
Common or Proper name gadodiamide injection USP gadodiamide injection USP
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients GADODIAMIDE GADODIAMIDE
Strength(s) 287MG 287MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20 mL 20 mL
ATC code V08CA V08CA
ATC description MAGNETIC RESONANCE IMAGING CONTRAST MEDIA MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-09-10 2019-09-10
Actual start date 2019-09-10 2019-09-10
Estimated end date 2019-09-16 2019-09-16
Actual end date 2019-09-16
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments